WebPhase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV ⩾ 100 cc Rikiya Onimaru, Hiroshi Onishi, Taro Shibata, Masahiro Hiraoka, Satoshi Ishikura, Katsuyuki Karasawa, Yukinori Matsuo, Masaki Kokubo, Yoshiyuki Shioyama, Haruo Matsushita, Yoshinori Ito, Hiroki … WebPhase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100 cc using a continual reassessment method (JCOG0702). Onimaru R, Shirato H, Shibata T, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Onishi H
overview of the medical-physics-related verification system for ...
WebAAPM Web5 ago 2015 · The RD of SBRT for peripheral T2N0M0 NSCLC with PTV<100 cc was determined to be 55 Gy in 4 fractions. Phase I study of stereotactic body radiation … huffy bicycles parts list
Phase I study of stereotactic body radiation therapy for peripheral ...
Web1 ago 2015 · We conducted a multi-institutional phase I study to estimate the maximum tolerated dose (MTD) and to determine the recommended dose (RD) of SBRT for patients with peripheral T2N0M0 NSCLC (JCOG0702). The enrolled patients were stratified into two subgroups: those with PTV < 100 cc and those with PTV ⩾ 100 cc, to assess the … WebDesign, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in … http://www.jcog.jp/document/0702.pdf holiday cinemas 14